Metabolic syndrome and the incidence of hepatocellular carcinoma: a meta-analysis of cohort studies

BACKGROUND: Patients with metabolic syndrome (MetS) were suggested to have a higher risk of hepatocellular carcinoma (HCC), although the results of previous cohort studies are not consistent. AIM: To perform an updated meta-analysis to evaluate the association between MetS and subsequent incidence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yongxin, Li, Xiaofei, Wu, Shuang, Ye, Weiwei, Lou, Lianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166758/
https://www.ncbi.nlm.nih.gov/pubmed/30310291
http://dx.doi.org/10.2147/OTT.S154848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166758/
https://www.ncbi.nlm.nih.gov/pubmed/30310291
http://dx.doi.org/10.2147/OTT.S154848

Ejemplares similares